Abstract
There is increasing evidence for the “cancer stem cell hypothesis” which holds that cancers originate in tissue stem cells or progenitor cells. As a result of this, cancers are driven by a cellular subcomponent that retains stem cell properties. Among these properties are self-renewal and multi-lineage differentiation. The biological processes which account for stem cell properties are currently being elucidated. Cancer stem cells maintain many of the same characteristics of their normal counterparts. The combination of biological research with mathematical modeling may provide for a greater understanding of the complex picture of breast cancer stem cells and assist cancer biologists and clinical oncologists in designing and testing novel therapeutic strategies.
Similar content being viewed by others
References
MacMahon, B. (2006). Epidemiology and the causes of breast cancer. International Journal of Cancer, 118, 2373–2378.
Shackleton, M., Vaillant, F., Simpson, K. J., Stingl, J., Smyth, G. K., Asselin-Labat, M. L., et al. (2006). Generation of a functional mammary gland from a single stem cell. Nature, 439, 84–88.
Dontu, G., Abdallah, W. M., Foley, J. M., Jackson, K. W., Clarke, M. F., Kawamura, M. J., et al. (2003). In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. General Development, 17, 1253–1270.
Li, Y., Welm, B., Podsypanina, K., Huang, S., Chamorro, M., Zhang, X., et al. (2003). Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proceedings of the National Academy Sciences of U.S.A., 100, 15853–15858.
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003). Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy Sciences of U.S.A., 100, 3983–3988.
Bonnet, D., & Dick, J. E. (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Medicine, 3, 730–737.
Singh, S. K., Clarke, I. D., Terasaki, M., Bonn, V. E., Hawkins, C., Squire, J., et al. (2003). Identification of a cancer stem cell in human brain tumors. Cancer Research, 63, 5821–5828.
Kim, C. F., Jackson, E. L., Woolfenden, A. E., Lawrence, S., Babar, I., Vogel, S., et al. (2005). Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell, 121, 823–835.
Ricci-Vitiani, L., Lombardi, D. G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C., et al. (2007). Identification and expansion of human colon-cancer-initiating cells. Nature, 445, 111–115.
O’Brien, C. A., Pollett, A., Gallinger, S., & Dick, J. E. (2007). A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature, 445, 106–110.
Collins, A. T., Berry, P. A., Hyde, C., Stower, M. J., & Maitland, N. J. (2005). Prospective identification of tumorigenic prostate cancer stem cells. Cancer Research, 65, 10946–10951.
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001). Stem cells, cancer and cancer stem cells. Nature, 414, 105–111.
Pardal, R., Clarke, M. F., & Morrison, S. J. (2003). Applying the principles of stem cell biology to cancer. Nature Reviews. Cancer, 3, 895–902.
Dontu, G., Al-Hajj, M., Abdallah, W. M., Clarke, M. F., & Wicha, M. S. (2003). Stem cells in normal breast development and breast cancer. Cell Proliferation, 36, 59–72.
Ganguli, R., & Puri, I. K. (2006). Mathematical modeling of the cancer stem cell hypothesis. Cell Proliferation, 39, 3–14.
Michor, F., Hughes, T. F., Iwasa, Y., Branford, S., Shah, N. P., Sawyers, C., et al. (2005). Dynamics of chronic myeloid leukaemia. Nature, 435, 1267–1270.
Angstreich, G. R., Smith, B. D., & Jones, R. J. (2004). Treatment options for chronic myeloid leukemia: imatinib versus interferon versus allogeneic transplant. Current Opinion in Oncology, 16, 95–99.
Ponti, D., Zaffaroni, N., Capelli, C., & Diadone, M. G. (2006). Breast cancer stem cells: An overview. European Journal of Cancer, 42, 1219–1224.
Ashkenazi, R., Heusel, S., & Jackson, T. L. Pathways to tumorigenesis-modeling mutation acquisition in stem cells and their progeny. (to be submitted)
Morrison, S. J., & Kimbel, J. (2006). Asymmetric and symmetric stem cell divisions in development and cancer. Nature, 441, 1068–1074.
Gompertz, B. (1899). On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies. In a letter to Francis Batly, Esq. F.R.S. Phil. Transactions of the Royal Society, 115, 513–585.
Norton, L., Simon, R., Brereton, H. D., & Bogden, A. E. (1976). Predicting the course of Gompertzian growth. Nature, 264, 542–545.
Norton, L., & Simon, R. (1977). Growth curve of an experimental solid tumor following radiotherapy. Journal of the National Cancer Institute, 58, 1735–1741.
Norton, L., & Simon, R. (1986). The Norton–Simon hypothesis revisited. Cancer Treatment and Research, 70, 163–169.
Norton, L. (2001). Theoretical concepts and the emerging role of taxanes in adjuvant therapy. Oncologist, 6, 30–35.
Norton, L. (2005). Conceptual and practical implications of breast tissue geometry: toward a more effective, less toxic therapy. The Oncologist, 10, 370–381.
Gyllenberg, M., & Webb, G. F. (1989). Quiescence as an explanation of Gompertzian tumor growth. Growth, Development, and Aging, 53, 25–33.
Dingli, D., & Michor, F. (2006). Successful therapy must eradicate cancer stem cells. Stem Cells, 24, 2603–2610.
Artavanis-Tsakonas, S., Rand, M. D., & Lake, J. R. (1999). Notch signaling: Cell fate control and signal integration in development. Science, 284, 770.
Miele, L., & Osborne, B. (1999). Arbiter of differentiation and death: Notch signaling meets apoptosis. Journal of Cellular Physiology, 181, 393–409.
Dontu, G., Jackson, K., McNicholas, E., Kawamura, M., Abdallah, W., & Wicha, M. S. (2004). Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Research, 6, R605–R615.
Siziopikou, K., Miao, H., Rizzo, P., Song, L., Selvaggi, S., Bashir, A. et al. (2003). Notch signaling is a therapeutic target in breast cancer. Proceedings of the 94th Annual Meeting of theAACR Abstract, 5575, 1277.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ashkenazi, R., Jackson, T.L., Dontu, G. et al. Breast Cancer Stem Cells-Research Opportunities Utilizing Mathematical Modeling. Stem Cell Rev 3, 176–182 (2007). https://doi.org/10.1007/s12015-007-0026-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12015-007-0026-2